Researchers from Flinders University and University of South Australia have unveiled a promising new strategy that could be used to treat the most aggressive forms of prostate cancer. Their study, published in British Journal of Cancer, explores the role of a novel drug, CDKI-73, to tackle drug-resistant prostate cancer that defies conventional therapies.
Medical Xpress – latest medical and health news stories
